_id
6915f43bbc934aba376b2283
Ticker
SBHMY
Name
Sino Biopharmaceutical Ltd ADR
Exchange
PINK
Address
Unit 09, Office Tower, Wan Chai, Hong Kong
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.sinobiopharm.com
Description
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, benmelstobart injection under Andewei brand, unecritinib fumarate capsules under Anboni brand, envonalkib citrate capsule under Anluoqing brand, garsorasib tablets under Anfangning brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, trastuzumab for injection under Saituo brand, and pertuzumab injection, under Paletan brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand, and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji. In addition, the company develops liver disease drugs, such as Lanifibranor and TQA2225; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide, TRD205, an AT2R inhibitor, and TRD303, a ropivacaine sustained-release solution. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Last Close
18.22
Volume
-
Current Price
17.65
Change
0
Last Updated
2026-01-06T10:46:52.146Z
Image
-
Ipo Date
-
Market Cap
23045038080
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
8787389000
Cost Of Revenue
1540542000
Gross Profit
7246847000
Operating Expenses
5365496000
Operating Income
1881352000
Interest Expense
-
Pretax Income
2983482000
Net Income
1694296000
Eps
1.879848828420257
Dividends Per Share
-
Shares Outstanding
894286099
Income Tax Expense
490662000
EBITDA
1977134000
Operating Margin
21.40968153338836
Total Other Income Expense Net
1102130000
Cash
19823304000
Short Term Investments
8718902000
Receivables
8154080000
Inventories
2103865000
Total Current Assets
33820318000
Property Plant Equipment
10053815000
Total Assets
74894406000
Payables
2820277000
Short Term Debt
8872451000
Long Term Debt
2999442000
Total Liabilities
29116691000
Equity
33373574000
Bs_currency_symbol
CNY
Depreciation
272891000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
29.3871
PB
0.4766596076134968
ROE
5.076759234716666
ROA
2.2622463952781735
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
58
Deep Value Investing Score
6.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
2
Quality Investing Score
4.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
8787389000
Quarters > 0 > income Statement > cost Of Revenue
1540542000
Quarters > 0 > income Statement > gross Profit
7246847000
Quarters > 0 > income Statement > operating Expenses
5365496000
Quarters > 0 > income Statement > operating Income
1881352000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
2983482000
Quarters > 0 > income Statement > net Income
1694296000
Quarters > 0 > income Statement > eps
1.879848828420257
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
901293750
Quarters > 0 > income Statement > income Tax Expense
490662000
Quarters > 0 > income Statement > EBITDA
1977134000
Quarters > 0 > income Statement > operating Margin
21.40968153338836
Quarters > 0 > income Statement > total Other Income Expense Net
1102130000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
19823304000
Quarters > 0 > balance Sheet > short Term Investments
8718902000
Quarters > 0 > balance Sheet > receivables
8154080000
Quarters > 0 > balance Sheet > inventories
2103865000
Quarters > 0 > balance Sheet > total Current Assets
33820318000
Quarters > 0 > balance Sheet > property Plant Equipment
10053815000
Quarters > 0 > balance Sheet > total Assets
74894406000
Quarters > 0 > balance Sheet > payables
2820277000
Quarters > 0 > balance Sheet > short Term Debt
8872451000
Quarters > 0 > balance Sheet > long Term Debt
2999442000
Quarters > 0 > balance Sheet > total Liabilities
29116691000
Quarters > 0 > balance Sheet > equity
33373574000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
1694295500
Quarters > 0 > cash Flow > depreciation
272891000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.879848828420257
Quarters > 0 > ratios > PB
0.4766596076134968
Quarters > 0 > ratios > ROE
5.076759234716666
Quarters > 0 > ratios > ROA
2.2622463952781735
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
58
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
8787389000
Quarters > 1 > income Statement > cost Of Revenue
1540542000
Quarters > 1 > income Statement > gross Profit
7246847000
Quarters > 1 > income Statement > operating Expenses
5365496000
Quarters > 1 > income Statement > operating Income
1881352000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
2983482000
Quarters > 1 > income Statement > net Income
1694296000
Quarters > 1 > income Statement > eps
1.879848828420257
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
901293750
Quarters > 1 > income Statement > income Tax Expense
490662000
Quarters > 1 > income Statement > EBITDA
1977134000
Quarters > 1 > income Statement > operating Margin
21.40968153338836
Quarters > 1 > income Statement > total Other Income Expense Net
1102130000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
19823304000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
8154080000
Quarters > 1 > balance Sheet > inventories
2103865000
Quarters > 1 > balance Sheet > total Current Assets
33820318000
Quarters > 1 > balance Sheet > property Plant Equipment
10053815000
Quarters > 1 > balance Sheet > total Assets
74894406000
Quarters > 1 > balance Sheet > payables
2820277000
Quarters > 1 > balance Sheet > short Term Debt
8872451000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
29116691000
Quarters > 1 > balance Sheet > equity
33373574000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
1694295500
Quarters > 1 > cash Flow > depreciation
272891000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
1.879848828420257
Quarters > 1 > ratios > PB
0.4766596076134968
Quarters > 1 > ratios > ROE
5.076759234716666
Quarters > 1 > ratios > ROA
2.2622463952781735
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
58
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
6495878000
Quarters > 2 > income Statement > cost Of Revenue
1245719000
Quarters > 2 > income Statement > gross Profit
5250159000
Quarters > 2 > income Statement > operating Expenses
3911197500
Quarters > 2 > income Statement > operating Income
1193261500
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
831726000
Quarters > 2 > income Statement > net Income
241336000
Quarters > 2 > income Statement > eps
0.2654920425202399
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
909014062
Quarters > 2 > income Statement > income Tax Expense
-181762500
Quarters > 2 > income Statement > EBITDA
1084488750
Quarters > 2 > income Statement > operating Margin
18.369518331471127
Quarters > 2 > income Statement > total Other Income Expense Net
-361535500
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
9569584000
Quarters > 2 > balance Sheet > short Term Investments
5027688000
Quarters > 2 > balance Sheet > receivables
5012638000
Quarters > 2 > balance Sheet > inventories
2373145000
Quarters > 2 > balance Sheet > total Current Assets
24685331000
Quarters > 2 > balance Sheet > property Plant Equipment
10288156000
Quarters > 2 > balance Sheet > total Assets
65408069000
Quarters > 2 > balance Sheet > payables
1497461000
Quarters > 2 > balance Sheet > short Term Debt
7703696000
Quarters > 2 > balance Sheet > long Term Debt
1996752000
Quarters > 2 > balance Sheet > total Liabilities
22633999000
Quarters > 2 > balance Sheet > equity
31960789000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
241336000
Quarters > 2 > cash Flow > depreciation
234963250
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.2654920425202399
Quarters > 2 > ratios > PB
0.5019931827809382
Quarters > 2 > ratios > ROE
0.7551002573810052
Quarters > 2 > ratios > ROA
0.3689697673233558
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
53
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
6495878000
Quarters > 3 > income Statement > cost Of Revenue
1245719000
Quarters > 3 > income Statement > gross Profit
5250159000
Quarters > 3 > income Statement > operating Expenses
3911197500
Quarters > 3 > income Statement > operating Income
1193261500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
831726000
Quarters > 3 > income Statement > net Income
241336000
Quarters > 3 > income Statement > eps
0.2654920425202399
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
909014062
Quarters > 3 > income Statement > income Tax Expense
-181762500
Quarters > 3 > income Statement > EBITDA
1090123500
Quarters > 3 > income Statement > operating Margin
18.369518331471127
Quarters > 3 > income Statement > total Other Income Expense Net
-361535500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
9569584000
Quarters > 3 > balance Sheet > short Term Investments
5027688000
Quarters > 3 > balance Sheet > receivables
4967560000
Quarters > 3 > balance Sheet > inventories
2373145000
Quarters > 3 > balance Sheet > total Current Assets
24685331000
Quarters > 3 > balance Sheet > property Plant Equipment
10288156000
Quarters > 3 > balance Sheet > total Assets
65408069000
Quarters > 3 > balance Sheet > payables
1497461000
Quarters > 3 > balance Sheet > short Term Debt
7703696000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
22633999000
Quarters > 3 > balance Sheet > equity
31960789000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
241336000
Quarters > 3 > cash Flow > depreciation
240598000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.2654920425202399
Quarters > 3 > ratios > PB
0.5019931827809382
Quarters > 3 > ratios > ROE
0.7551002573810052
Quarters > 3 > ratios > ROA
0.3689697673233558
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
53
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
28866159000
Annuals > 0 > income Statement > cost Of Revenue
5336218000
Annuals > 0 > income Statement > gross Profit
23529941000
Annuals > 0 > income Statement > operating Expenses
17394379000
Annuals > 0 > income Statement > operating Income
6135562000
Annuals > 0 > income Statement > interest Expense
295117000
Annuals > 0 > income Statement > pretax Income
5277468000
Annuals > 0 > income Statement > net Income
3499834000
Annuals > 0 > income Statement > eps
3.8259879989461636
Annuals > 0 > income Statement > dividends Per Share
-1846381000
Annuals > 0 > income Statement > shares Outstanding
914753000
Annuals > 0 > income Statement > income Tax Expense
492918000
Annuals > 0 > income Statement > EBITDA
6108662000
Annuals > 0 > income Statement > operating Margin
21.25520752518546
Annuals > 0 > income Statement > total Other Income Expense Net
-858094000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
9569584000
Annuals > 0 > balance Sheet > short Term Investments
5027688000
Annuals > 0 > balance Sheet > receivables
5012638000
Annuals > 0 > balance Sheet > inventories
2373145000
Annuals > 0 > balance Sheet > total Current Assets
24685331000
Annuals > 0 > balance Sheet > property Plant Equipment
10288156000
Annuals > 0 > balance Sheet > total Assets
65408069000
Annuals > 0 > balance Sheet > payables
1497461000
Annuals > 0 > balance Sheet > short Term Debt
7703696000
Annuals > 0 > balance Sheet > long Term Debt
1996752000
Annuals > 0 > balance Sheet > total Liabilities
22633999000
Annuals > 0 > balance Sheet > equity
31960789000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
6994375000
Annuals > 0 > cash Flow > depreciation
1321181000
Annuals > 0 > cash Flow > change In Working Capital
99839000
Annuals > 0 > cash Flow > cash From Operations
6615120000
Annuals > 0 > cash Flow > capital Expenditures
1394160000
Annuals > 0 > cash Flow > cash From Investing
-1709126000
Annuals > 0 > cash Flow > cash From Financing
-6315086000
Annuals > 0 > cash Flow > net Change In Cash
-1273575000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
3.8259879989461636
Annuals > 0 > ratios > PB
0.5214764773172527
Annuals > 0 > ratios > ROE
10.950399253285017
Annuals > 0 > ratios > ROA
5.350767961059972
Annuals > 0 > ratios > FCF
5220960000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.18086784597839983
Annuals > 0 > health Score
76
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
26199409000
Annuals > 1 > income Statement > cost Of Revenue
4989877000
Annuals > 1 > income Statement > gross Profit
21209532000
Annuals > 1 > income Statement > operating Expenses
15539653000
Annuals > 1 > income Statement > operating Income
5785714000
Annuals > 1 > income Statement > interest Expense
495237000
Annuals > 1 > income Statement > pretax Income
5409906000
Annuals > 1 > income Statement > net Income
2331939000
Annuals > 1 > income Statement > eps
2.517060639668804
Annuals > 1 > income Statement > dividends Per Share
-632669000
Annuals > 1 > income Statement > shares Outstanding
926453246
Annuals > 1 > income Statement > income Tax Expense
797267000
Annuals > 1 > income Statement > EBITDA
6979427000
Annuals > 1 > income Statement > operating Margin
22.083376002870907
Annuals > 1 > income Statement > total Other Income Expense Net
-375808000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
9451878000
Annuals > 1 > balance Sheet > short Term Investments
1553257000
Annuals > 1 > balance Sheet > receivables
4596202000
Annuals > 1 > balance Sheet > inventories
1993472000
Annuals > 1 > balance Sheet > total Current Assets
23805531000
Annuals > 1 > balance Sheet > property Plant Equipment
9912161000
Annuals > 1 > balance Sheet > total Assets
63604819000
Annuals > 1 > balance Sheet > payables
1334703000
Annuals > 1 > balance Sheet > short Term Debt
11207428000
Annuals > 1 > balance Sheet > long Term Debt
1074422000
Annuals > 1 > balance Sheet > total Liabilities
25434866000
Annuals > 1 > balance Sheet > equity
30474469000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
5933579000
Annuals > 1 > cash Flow > depreciation
1074284000
Annuals > 1 > cash Flow > change In Working Capital
-430514000
Annuals > 1 > cash Flow > cash From Operations
6065734000
Annuals > 1 > cash Flow > capital Expenditures
1703709000
Annuals > 1 > cash Flow > cash From Investing
-756975000
Annuals > 1 > cash Flow > cash From Financing
-6548990000
Annuals > 1 > cash Flow > net Change In Cash
-1149707000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
2.517060639668804
Annuals > 1 > ratios > PB
0.5539055706637579
Annuals > 1 > ratios > ROE
7.652107080192275
Annuals > 1 > ratios > ROA
3.6662929580854557
Annuals > 1 > ratios > FCF
4362025000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.1664932594471883
Annuals > 1 > health Score
70
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
26026164000
Annuals > 2 > income Statement > cost Of Revenue
5795510000
Annuals > 2 > income Statement > gross Profit
21538548000
Annuals > 2 > income Statement > operating Expenses
15952724000
Annuals > 2 > income Statement > operating Income
5585824000
Annuals > 2 > income Statement > interest Expense
429494000
Annuals > 2 > income Statement > pretax Income
5214869000
Annuals > 2 > income Statement > net Income
2543570000
Annuals > 2 > income Statement > eps
2.6750202320510037
Annuals > 2 > income Statement > dividends Per Share
1267622000
Annuals > 2 > income Statement > shares Outstanding
950860098
Annuals > 2 > income Statement > income Tax Expense
696716000
Annuals > 2 > income Statement > EBITDA
6691347000
Annuals > 2 > income Statement > operating Margin
21.4623407429539
Annuals > 2 > income Statement > total Other Income Expense Net
-370955000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
8654805000
Annuals > 2 > balance Sheet > short Term Investments
8266858000
Annuals > 2 > balance Sheet > receivables
4643443000
Annuals > 2 > balance Sheet > inventories
2328844000
Annuals > 2 > balance Sheet > total Current Assets
25934905000
Annuals > 2 > balance Sheet > property Plant Equipment
9251183000
Annuals > 2 > balance Sheet > total Assets
64064284000
Annuals > 2 > balance Sheet > payables
1883800000
Annuals > 2 > balance Sheet > short Term Debt
9723841000
Annuals > 2 > balance Sheet > long Term Debt
3933859000
Annuals > 2 > balance Sheet > total Liabilities
26120736000
Annuals > 2 > balance Sheet > equity
29747035000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
5778604000
Annuals > 2 > cash Flow > depreciation
1046984000
Annuals > 2 > cash Flow > change In Working Capital
-195595000
Annuals > 2 > cash Flow > cash From Operations
6265155000
Annuals > 2 > cash Flow > capital Expenditures
1705612000
Annuals > 2 > cash Flow > cash From Investing
-4070819000
Annuals > 2 > cash Flow > cash From Financing
-3186390000
Annuals > 2 > cash Flow > net Change In Cash
-944732000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
2.6750202320510037
Annuals > 2 > ratios > PB
0.5823999260954915
Annuals > 2 > ratios > ROE
8.550667318608392
Annuals > 2 > ratios > ROA
3.9703401664490623
Annuals > 2 > ratios > FCF
4559543000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.17519074266956897
Annuals > 2 > health Score
72
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
26861356000
Annuals > 3 > income Statement > cost Of Revenue
5332095000
Annuals > 3 > income Statement > gross Profit
21529261000
Annuals > 3 > income Statement > operating Expenses
17185822000
Annuals > 3 > income Statement > operating Income
5078556000
Annuals > 3 > income Statement > interest Expense
308617000
Annuals > 3 > income Statement > pretax Income
18572673000
Annuals > 3 > income Statement > net Income
14608412000
Annuals > 3 > income Statement > eps
15.151632102030005
Annuals > 3 > income Statement > dividends Per Share
938489000
Annuals > 3 > income Statement > shares Outstanding
964147750
Annuals > 3 > income Statement > income Tax Expense
1957880000
Annuals > 3 > income Statement > EBITDA
19873846000
Annuals > 3 > income Statement > operating Margin
18.906551106355167
Annuals > 3 > income Statement > total Other Income Expense Net
13494117000
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
9599537000
Annuals > 3 > balance Sheet > short Term Investments
6194514000
Annuals > 3 > balance Sheet > receivables
4285239000
Annuals > 3 > balance Sheet > inventories
1937741000
Annuals > 3 > balance Sheet > total Current Assets
23503178000
Annuals > 3 > balance Sheet > property Plant Equipment
8516062000
Annuals > 3 > balance Sheet > total Assets
60543337000
Annuals > 3 > balance Sheet > payables
1794684000
Annuals > 3 > balance Sheet > short Term Debt
6585038000
Annuals > 3 > balance Sheet > long Term Debt
5212526000
Annuals > 3 > balance Sheet > total Liabilities
22814314000
Annuals > 3 > balance Sheet > equity
30291116000
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
18572673000
Annuals > 3 > cash Flow > depreciation
992556000
Annuals > 3 > cash Flow > change In Working Capital
-339135000
Annuals > 3 > cash Flow > cash From Operations
5366294000
Annuals > 3 > cash Flow > capital Expenditures
1893984000
Annuals > 3 > cash Flow > cash From Investing
-2515977000
Annuals > 3 > cash Flow > cash From Financing
-3225263000
Annuals > 3 > cash Flow > net Change In Cash
-1024657000
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
15.151632102030005
Annuals > 3 > ratios > PB
0.5799314889883885
Annuals > 3 > ratios > ROE
48.22672099634758
Annuals > 3 > ratios > ROA
24.128851701715746
Annuals > 3 > ratios > FCF
3472310000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.12926785974617216
Annuals > 3 > health Score
79
Valuation > metrics > PE
29.3871
Valuation > metrics > PB
0.4766596076134968
Valuation > final Score
64.73548
Valuation > verdict
17.4% Undervalued
Profitability > metrics > ROE
5.076759234716666
Profitability > metrics > ROA
5.009698607801381
Profitability > metrics > Net Margin
0.1928099461626201
Profitability > final Score
54
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8724474939363701
Risk > metrics > Interest Coverage
1.8694845123158192
Risk > final Score
55
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.892423222365217
Liquidity > metrics > Quick Ratio
2.712493867983588
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
54
Prev Profitabilities > 1
10
Prev Profitabilities > 2
10
Prev Risks > 0
55
Prev Risks > 1
67
Prev Risks > 2
66
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:31:52.605Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-18
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-26
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.19
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.19
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-29
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.03
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.03
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-06-30
Earnings History > 3 > report Date
2021-06-30
Earnings History > 3 > date
2021-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CNY
Earnings History > 3 > eps Actual
1.0562
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-03-31
Earnings History > 4 > report Date
2021-06-30
Earnings History > 4 > date
2021-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CNY
Earnings History > 4 > eps Actual
0.0528
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-12-31
Earnings History > 5 > report Date
2021-03-31
Earnings History > 5 > date
2020-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
0.0142
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-09-30
Earnings History > 6 > report Date
2020-12-31
Earnings History > 6 > date
2020-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
0.0076
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-09-30
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
0.005
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-06-30
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
0.0027
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-31
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0.0052
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-12-31
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
0.0039
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-06-30
Earnings History > 11 > report Date
2019-09-30
Earnings History > 11 > date
2019-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
0.006
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-03-31
Earnings History > 12 > report Date
2019-06-30
Earnings History > 12 > date
2019-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
0.0045
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-12-31
Earnings History > 13 > report Date
2019-03-31
Earnings History > 13 > date
2018-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
0.0068
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-09-30
Earnings History > 14 > report Date
2018-12-31
Earnings History > 14 > date
2018-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
0.0542
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-06-30
Earnings History > 15 > report Date
2018-09-30
Earnings History > 15 > date
2018-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
0.0064
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2018-03-31
Earnings History > 16 > report Date
2018-06-30
Earnings History > 16 > date
2018-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
0.0047
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-12-31
Earnings History > 17 > report Date
2018-03-31
Earnings History > 17 > date
2017-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
0.0068
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-09-30
Earnings History > 18 > report Date
2017-12-31
Earnings History > 18 > date
2017-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
0.0039
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2017-06-30
Earnings History > 19 > report Date
2017-09-30
Earnings History > 19 > date
2017-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
0.0061
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0.0061
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2017-03-31
Earnings History > 20 > report Date
2017-06-30
Earnings History > 20 > date
2017-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
0.0042
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.0042
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-12-31
Earnings History > 21 > report Date
2017-03-31
Earnings History > 21 > date
2016-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
0.005
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.005
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2016-09-30
Earnings History > 22 > report Date
2016-12-31
Earnings History > 22 > date
2016-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
0.0021
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.0021
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2016-06-30
Earnings History > 23 > report Date
2016-09-30
Earnings History > 23 > date
2016-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CNY
Earnings History > 23 > eps Actual
0.0042
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0042
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2016-03-31
Earnings History > 24 > report Date
2016-06-30
Earnings History > 24 > date
2016-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CNY
Earnings History > 24 > eps Actual
0.004
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.004
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-12-31
Earnings History > 25 > report Date
2016-03-31
Earnings History > 25 > date
2015-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CNY
Earnings History > 25 > eps Actual
0.004
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.004
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2015-09-30
Earnings History > 26 > report Date
2015-12-31
Earnings History > 26 > date
2015-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CNY
Earnings History > 26 > eps Actual
0.003
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.003
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2015-06-30
Earnings History > 27 > report Date
2015-09-30
Earnings History > 27 > date
2015-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CNY
Earnings History > 27 > eps Actual
0.0036
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.0036
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2015-03-31
Earnings History > 28 > report Date
2015-06-30
Earnings History > 28 > date
2015-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CNY
Earnings History > 28 > eps Actual
0.0041
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0.0041
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-12-31
Earnings History > 29 > report Date
2015-03-31
Earnings History > 29 > date
2014-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CNY
Earnings History > 29 > eps Actual
0.0031
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
0.0031
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2014-09-30
Earnings History > 30 > report Date
2014-12-31
Earnings History > 30 > date
2014-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CNY
Earnings History > 30 > eps Actual
0.0028
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.0028
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2014-06-30
Earnings History > 31 > report Date
2014-09-30
Earnings History > 31 > date
2014-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CNY
Earnings History > 31 > eps Actual
0.0041
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.0041
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2014-03-31
Earnings History > 32 > report Date
2014-06-30
Earnings History > 32 > date
2014-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
CNY
Earnings History > 32 > eps Actual
0.0023
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
0.0023
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2013-12-31
Earnings History > 33 > report Date
2014-03-31
Earnings History > 33 > date
2013-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
CNY
Earnings History > 33 > eps Actual
0.0026
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
0.0026
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2013-09-30
Earnings History > 34 > report Date
2013-12-31
Earnings History > 34 > date
2013-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
CNY
Earnings History > 34 > eps Actual
0.0016
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
0.0016
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2013-06-30
Earnings History > 35 > report Date
2013-09-30
Earnings History > 35 > date
2013-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
CNY
Earnings History > 35 > eps Actual
0.0027
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
0.0027
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2013-03-31
Earnings History > 36 > report Date
2013-06-30
Earnings History > 36 > date
2013-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
CNY
Earnings History > 36 > eps Actual
0.0017
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
0.0017
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2012-12-31
Earnings History > 37 > report Date
2013-03-31
Earnings History > 37 > date
2012-12-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
CNY
Earnings History > 37 > eps Actual
0.002
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
0.002
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2012-09-30
Earnings History > 38 > report Date
2012-12-31
Earnings History > 38 > date
2012-09-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
CNY
Earnings History > 38 > eps Actual
0.002
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
0.002
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2012-06-30
Earnings History > 39 > report Date
2012-09-30
Earnings History > 39 > date
2012-06-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
CNY
Earnings History > 39 > eps Actual
0.0022
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
0.0022
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2012-03-31
Earnings History > 40 > report Date
2012-06-30
Earnings History > 40 > date
2012-03-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
CNY
Earnings History > 40 > eps Actual
0.0011
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
0.0011
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2011-12-31
Earnings History > 41 > report Date
2012-03-31
Earnings History > 41 > date
2011-12-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
CNY
Earnings History > 41 > eps Actual
0.0016
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
0.0016
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2011-09-30
Earnings History > 42 > report Date
2011-12-31
Earnings History > 42 > date
2011-09-30
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
CNY
Earnings History > 42 > eps Actual
0.0014
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
0.0014
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2011-06-30
Earnings History > 43 > report Date
2011-09-30
Earnings History > 43 > date
2011-06-30
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
CNY
Earnings History > 43 > eps Actual
0.0005
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
0.0005
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2011-03-31
Earnings History > 44 > report Date
2011-06-30
Earnings History > 44 > date
2011-03-31
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
CNY
Earnings History > 44 > eps Actual
0.0009
Earnings History > 44 > eps Estimate
0
Earnings History > 44 > eps Difference
0.0009
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2010-12-31
Earnings History > 45 > report Date
2011-03-31
Earnings History > 45 > date
2010-12-31
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
CNY
Earnings History > 45 > eps Actual
0.0008
Earnings History > 45 > eps Estimate
0
Earnings History > 45 > eps Difference
0.0008
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2010-09-30
Earnings History > 46 > report Date
2010-12-31
Earnings History > 46 > date
2010-09-30
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
CNY
Earnings History > 46 > eps Actual
0.0018
Earnings History > 46 > eps Estimate
0
Earnings History > 46 > eps Difference
0.0018
Earnings History > 46 > surprise Percent
-
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, benmelstobart injection under Andewei brand, unecritinib fumarate capsules under Anboni brand, envonalkib citrate capsule under Anluoqing brand, garsorasib tablets under Anfangning brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, trastuzumab for injection under Saituo brand, and pertuzumab injection, under Paletan brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand, and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji. In addition, the company develops liver disease drugs, such as Lanifibranor and TQA2225; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide, TRD205, an AT2R inhibitor, and TRD303, a ropivacaine sustained-release solution. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sino Biopharmaceutical Ltd ADR
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
0.19
EPS Estimate
0
EPS Difference
0.19
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.